Musculoskeletal disorders and coronary artery disease —promising molecular markers: literature review [PDF]
КардиоСоматикаCurrently, increasing evidence shows that people with cardiovascular diseases, including coronary heart disease, have a higher risk of developing pathologies such as sarcopenia, osteopenia, osteosarcopenia, sarcopenic, and osteosarcopenic obesity, which ...
Viktoria N. Karetnikova +3 more
doaj +3 more sources
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
Diabetes, Metabolic Syndrome and Obesity, 2020 Valentina Guarnotta, Antonio Prinzi, Maria Pitrone, Giuseppe Pizzolanti, Carla Giordano Dipartimento di Promozione Della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza “G.
Guarnotta V +4 more
doaj +2 more sources
Metformin and tBHQ Treatment Combined with an Exercise Regime Prevents Osteosarcopenic Obesity in Middle-Aged Wistar Female Rats. [PDF]
Oxid Med Cell Longev, 2021 Osteosarcopenic obesity (OSO) is characterized by bone density, mass, and muscle strength loss, in conjunction with adipose tissue increase. OSO impairs physical activity and mobility, provoking autonomy loss; also, it is known that augmenting body fat in the elderly decreases life expectancy.
Toledo-Pérez R +8 more
europepmc +2 more sources
Low-Intensity Exercise Routine for a Long Period of Time Prevents Osteosarcopenic Obesity in Sedentary Old Female Rats, by Decreasing Inflammation and Oxidative Stress and Increasing GDF-11. [PDF]
Oxid Med Cell Longev, 2021 The loss of skeletal muscle mass and strength is known as sarcopenia; it is characterized as a progressive and generalized muscle disorder associated with aging. This deterioration can seriously compromise the elderly’s health and reduce their quality of life.
Mena-Montes B +11 more
europepmc +2 more sources
Preventing Osteoporosis, Sarcopenia and Obesity to Care about Quality of Life [PDF]
Annals of Geriatric Medicine and Research, 2023 A recent review by Kumari and Khanna examined the prevalence of sarcopenic obesity using various comorbidities, diagnostic markers, and possible therapeutic approaches. The authors discussed the strong impact of sarcopenic obesity on quality of life (QoL)
Stefano Cacciatore +2 more
doaj +1 more source
OSTEOSARCOPENIC OBESITY: FREQUENCY AND ITS RELATION WITH FRAILTY AND PHYSICAL PERFORMANCE [PDF]
Innov Aging, 2017 Szlejf C +2 more
europepmc +3 more sources
Inflammaging in the pathogenesis of chronic noncommunicable diseases
Кардиоваскулярная терапия и профилактика, 2021 See Krivoshapova K. E., Masenko V. L., Bazdyrev E. D., Barbarash O. L. Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues in Review articles, pp. 9298.
O. T. Kim
doaj +1 more source
Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults – The Yishun Study
Osteoporosis and Sarcopenia, 2021 Objectives: To 1) report prevalence of ‘osteosarcopenia’ (OS) and osteosarcopenic obesity (OSO) entities using evidence-based diagnostic techniques and definitions, 2) examine if OSO offers additional predictive value of functional decline over its ...
Benedict Wei Jun Pang +9 more
doaj +1 more source
A Clinical Study of Structural Properties of Osteosarcopenic Obesity Syndrome Using Multivariate Statistical Methods [PDF]
Zhongguo quanke yixue, 2022 Background Osteosarcopenic obesity syndrome (OSO) is a disease that seriously endangers the health of older people. The rational classification of the disease can guide the clinical diagnosis and treatment.
Yizhen NIE, Zhaoqi YAN, Wei YAN, Hongmei FU, Xingjuan ZHAO, Hui YIN, Qunhong WU
doaj +1 more source
Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain) [PDF]
, 2022 Summary The associations of sarcopenia with osteoporosis or obesity have a very low prevalence. No trend towards an association between osteoporosis and sarcopenia is observed.
González Macías, Jesús +4 more
core +1 more source